Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment

Metab Brain Dis. 2016 Feb;31(1):93-107. doi: 10.1007/s11011-015-9691-z. Epub 2015 Jun 20.

Abstract

The interaction between MDMA and Nicotine affects multiple brain centres and neurotransmitter systems (serotonin, dopamine and glutamate) involved in motor coordination and cognition. In this study, we have elucidated the effect of prolonged (10 days) MDMA, Nicotine and a combined Nicotine-MDMA treatment on motor-cognitive neural functions. In addition, we have shown the correlation between the observed behavioural change and neural structural changes induced by these treatments in BALB/c mice. We observed that MDMA (2 mg/Kg body weight; subcutaneous) induced a decline in motor function, while Nicotine (2 mg/Kg body weight; subcutaneous) improved motor function in male periadolescent mice. In combined treatment, Nicotine reduced the motor function decline observed in MDMA treatment, thus no significant change in motor function for the combined treatment versus the control. Nicotine or MDMA treatment reduced memory function and altered hippocampal structure. Similarly, a combined Nicotine-MDMA treatment reduced memory function when compared with the control. Ultimately, the metabolic and structural changes in these neural systems were seen to vary for the various forms of treatment. It is noteworthy to mention that a combined treatment increased the rate of lipid peroxidation in brain tissue.

Keywords: Behaviour; Hippocampus; MDMA; Motor cortex; Nicotine; Striatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Body Weight / drug effects
  • Drug Interactions
  • Hallucinogens / toxicity*
  • Hippocampus / pathology
  • Lipid Peroxidation / drug effects
  • Male
  • Memory Disorders / chemically induced
  • Memory Disorders / psychology
  • Mice
  • Mice, Inbred BALB C
  • Motor Cortex / drug effects
  • Motor Cortex / pathology
  • Motor Skills / drug effects
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity*
  • Neostriatum / drug effects
  • Neostriatum / pathology
  • Nicotine / toxicity*
  • Nicotinic Agonists / toxicity*
  • Postural Balance / drug effects
  • Recognition, Psychology / drug effects

Substances

  • Hallucinogens
  • Nicotinic Agonists
  • Nicotine
  • N-Methyl-3,4-methylenedioxyamphetamine